首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 140 毫秒
1.
医学论文具有专业分支多、学术性强等特点,其质量的优劣,是决定期刊质量的关键.审稿专家作为医学论文科学性、创新性的鉴定者和把关者,在稿件的审理和取舍方面,起着至关重要的作用.本文从不同方面对医学专家在审稿中常见的问题进行了分析,并提出了相应对策,旨在进一步完善审稿制度,加强期刊审稿专家队伍的建设,切实提高医学期刊的学术质量.  相似文献   

2.
以《重庆医学》杂志《循证医学》栏目论文为例,分析循证医学论文常见的审稿要点,探讨提高期刊编辑学术能力的途径和方法.  相似文献   

3.
冷怀明  罗长坤 《编辑学报》2005,17(5):360-361
分析医科大学学报的来稿范围局限:医学论文的科研设计与统计学问题较多,审稿专家局限校内,同行专家难找,临床专家较忙不能按时完成审稿任务等.提出建立医科大学学报同行专家审稿指标体系和运行机制应注意的问题,为建立有针对性的同行专家审稿机制提供依据.  相似文献   

4.
罗巧 《编辑学报》2017,29(3):236-238
根据医学论文研究类型的不同,总结在编辑过程中从医学专业角度对“材料与方法”部分的审编重点,同时对此部分常见问题进行评析,提出提高编辑医学专业水平、加强与审稿专家交流、保持学术质疑和注重归纳总结等对策.  相似文献   

5.
医学论文中数据占很大的比重,医学论文数据造假违背了学术道德和科学精神,严重影响期刊的质量和作者的声誉。本文从《临床骨科杂志》编辑部近些年的审稿和编校经验出发,在分析临床医学论文数据特点及数据造假危害性的基础上,重点探讨医学期刊在打击论文数据造假中的守门人和啄木鸟式正面角色,以及在助长论文数据造假中的鸵鸟式、协助者和共谋者负面角色,以期提高期刊编辑在审稿和编校过程中对医学论文数据造假的认识。  相似文献   

6.
论述了医学论文的评价标准,医学论文的选题过程,以及医学论文写作与医学文献信息检索的关系。最后介绍了医学文献检索的方法。  相似文献   

7.
"审稿报告单"的设计   总被引:1,自引:0,他引:1  
韩志伟 《编辑学报》2006,18(2):139-141
对审稿报告单格式化的意义、依据、设计原则、设计方法及其内容与格式作了分析研究.认为设计格式化的审稿报告单具有引导审稿、便利审稿、节省时间和宣传学术规范的作用.审稿报告单的设计依据是论文学术价值和质量构成所具有的可剖析性和审稿人具有对应的剖析评价能力.提出了设计的4项原则:规范性、简明性、量化适中性和学科专业匹配性原则.给出了启问在先、评价跟进、建议随后的3步设计方法,并将审稿报告单的内容概括为3部分.这为审稿报告单的设计提供了一些理论和方法上的借鉴.  相似文献   

8.
医学论文中定性资料假设检验方法的常见错误分析   总被引:2,自引:1,他引:1  
张功员 《编辑学报》2002,14(3):184-186
分析医学论文中使用定性资料假设检验方法的常见错误.认为论文作者在使用统计方法时应掌握其适用条件,编者应加强对文稿统计学使用的审查工作.  相似文献   

9.
审稿质量评价的指标体系   总被引:6,自引:6,他引:6  
朱美香 《编辑学报》2005,17(2):99-100
为了进一步摸索审稿工作的规律,建立了一套审稿质量评价指标体系,以便跟踪审稿情况,从而及时调整审稿工作,保证和提高期刊的审稿质量.利用这一体系对<湘潭大学学报>2002-2003年所刊载的234篇论文的审稿质量进行了评价,结果表明:所建立的审稿质量评价指标和权重基本合理、可行,能客观、全面地反映审稿专家的审稿质量;同时,能增强审稿人的责任意识,减少审稿失误.  相似文献   

10.
关于审稿的对话   总被引:7,自引:2,他引:5  
钱寿初 《编辑学报》2000,12(4):220-221
编辑:现在请您来一同讨论一下关于生物医学论文审稿的问题.审稿制度在科技界使用很广泛.一般有一个共识:某项科研成果让同一学科领域的科学家来评论其研究工作的原始性、可靠性及其价值最可靠.但这种做法也有许多不足的地方,而且苦于找不到改进的良策[1,2].据说有个由科学家和编辑家组成的组织,叫Locknet[3],正在想法找出如何评价审稿的量化方法,来完善这一制度.  相似文献   

11.
The number of clinical citations received from clinical guidelines or clinical trials has been considered as one of the most appropriate indicators for quantifying the clinical impact of biomedical papers. Therefore, the early prediction of clinical citation count of biomedical papers is critical to scientific activities in biomedicine, such as research evaluation, resource allocation, and clinical translation. In this study, we designed a four-layer multilayer perceptron neural network (MPNN) model to predict the clinical citation count of biomedical papers in the future by using 9,822,620 biomedical papers published from 1985 to 2005. We extracted ninety-one paper features from three dimensions as the input of the model, including twenty-one features in the paper dimension, thirty-five in the reference dimension, and thirty-five in the citing paper dimension. In each dimension, the features can be classified into three categories, i.e., the citation-related features, the clinical translation-related features, and the topic-related features. Besides, in the paper dimension, we also considered the features that have previously been demonstrated to be related to the citation counts of research papers. The results showed that the proposed MPNN model outperformed the other five baseline models, and the features in the reference dimension were the most important. In all the three dimensions, the citation-related and topic-related features were more important than the clinical translation-related features for the prediction. It also turned out that the features helpful in predicting the citation count of papers are not important for predicting the clinical citation count of biomedical papers. Furthermore, we explored the MPNN model based on different categories of biomedical papers. The results showed that the clinical translation-related features were more important for the prediction of clinical citation count of basic papers rather than those papers closer to clinical science. This study provided a novel dimension (i.e., the reference dimension) for the research community and could be applied to other related research tasks, such as the research assessment for translational programs. In addition, the findings in this study could be useful for biomedical authors (especially for those in basic science) to get more attention from clinical research.  相似文献   

12.
论文围绕一种全新的文献在线评估系统———F1000,分析其对学术论文的评价原理和衡量机制。与传统的学术科研评价体系比较,F1000的专家评议机制能够及时准确的对优秀文献做出推荐,对生物医学领域青年人才学术水平的评估具有极高的参考性。  相似文献   

13.
F1000是一个新的科研文献在线评估系统,它提供了一种系统的结构化的专家评议机制.通过与ISI Web Of Science中由被引次数所确定的影响力较高的文献对比,F1000 的专家评议机制能够及时准确的对优秀文献做出推荐,并给出推荐的评语和文献重要程度等级,对文献质量的评定具有极高的参考性,也对科研工作者快速选择相...  相似文献   

14.
Peer review is well established across most academic disciplines, and publishers, editors, and researchers devote considerable resources to it. This paper uses examples from biomedical journals to examine its shortcomings. Although mainly anecdotal, the evidence suggests that peer review is sometimes ineffective at identifying important research and even less effective at detecting fraud. Most reviewers identify only the minority of a paper's defects and they may be biased. Peer review plus other editorial processes are associated with improvements in papers between submission and publication, but published papers remain hard to read and a significant proportion contain errors or omissions. While it is hard to quantify the costs, peer review does not seem an efficient use of resources. Research into the outcomes of peer review, the establishment of sound methods for measuring the quality of the process and its outcomes, and comparisons with alternative methods are needed.  相似文献   

15.
Demonstrating the practical value of public research has been an important subject in science policy. Here we present a detailed study on the evolution of the citation linkage between life science related patents and biomedical research over a 37-year period. Our analysis relies on a newly-created dataset that systematically links millions of non-patent references to biomedical papers. We find a large disparity in the volume of citations to science among technology sectors, with biotechnology and drug patents dominating it. The linkage has been growing exponentially over a long period of time, doubling every 2.9 years. The U.S. has been the largest producer of cited science for years, receiving nearly half of the citations. More than half of citations goes to universities. We use a new paper-level indicator to quantify to what extent a paper is basic research or clinical medicine. We find that the cited papers are likely to be basic research, yet a significant portion of papers cited in patents that are related to FDA-approved drugs are clinical research. The U.S. National Institute of Health continues to be an important funder of cited science. For the majority of companies, more than half of citations in their patents are authored by public research. Taken together, these results indicate a continuous linkage of public science to private sector inventions.  相似文献   

16.
补充计量学是一种基于社交网络的计量指标,可作为文献计量学的补充,对学术论文进行评价.本文介绍了补充计量学的定义、特点与常用工具,提出了补充计量学在生物医学信息计量学研究中的作用.  相似文献   

17.
Biomedical research encompasses diverse types of activities, from basic science (“bench”) to clinical medicine (“bedside”) to bench-to-bedside translational research. It, however, remains unclear whether different types of research receive citations at varying rates. Here we aim to answer this question by using a newly proposed paper-level indicator that quantifies the extent to which a paper is basic science or clinical medicine. Applying this measure to 5 million biomedical papers, we find a systematic citation disadvantage of clinical oriented papers; they tend to garner far fewer citations and are less likely to be hit works than papers oriented towards basic science. At the same time, clinical research has a higher variance in its citation. We also find that the citation difference between basic and clinical research decreases, yet still persists, if longer citation-window is used. Given the increasing adoption of short-term, citation-based bibliometric indicators in funding decisions, the under-cited effect of clinical research may provide disincentives for bio-researchers to venture into the translation of basic scientific discoveries into clinical applications, thus providing explanations of reasons behind the existence of the gap between basic and clinical research that is commented as “valley of death” and the commentary of “extinction” risk of translational researchers. Our work may provide insights to policy-makers on how to evaluate different types of biomedical research.  相似文献   

18.
[目的/意义]通过对2020年国际数字图书馆联合会议(Joint Conference on Digital Libraries,JCDL)的录用论文进行整体回顾,梳理与分析当下数字图书馆的研究内容与研究发现,为我国相关领域学者把握学科前沿提供参考。[研究设计/方法]采用文献综述法,对本届年会论文所反映的研究热点与前沿进行归纳总结与提炼。[结论/发现]本届年会覆盖研究主题广泛,呈现出与数据科学协同合作的趋势,聚焦于用户信息活动的探索、未来图书馆的建设、细粒度化与精准化智慧服务的提供等方面,具有较明显的跨学科特性,且在新型冠状病毒肺炎的公共卫生危机下更加关注生物医学信息学的价值。[创新/价值]揭示了当前图书情报与信息科学的研究热点与趋势。  相似文献   

19.
Although the novelty of scientific publications has been the subject of previous studies, most have examined the distribution of references in the bibliography, which may not be effective in capturing implied scientific knowledge. We propose an analytical framework for measuring the novelty of scientific publications using a paper's title. At the heart of the framework, fastText is used to construct a vector space model in which papers with similar scientific knowledge are located close to each other, and the local outlier factor is used to measure the novelty of scientific knowledge implied in the papers on a numerical scale. The feasibility and validity of the analytical framework were assessed by comparing the average novelty scores of papers recommended with novelty-related tags in Faculty Opinions to those of papers without such tags. This case study of 15,653 papers published in a biomedical journal confirms that our framework is a useful complementary tool for the continuous assessment of the novelty of scientific publications and can serve as a starting point for developing more general models.  相似文献   

20.
国内外生物医学期刊稿件中医学伦理学意识比较   总被引:12,自引:1,他引:11  
为了了解近年来我国与西方国家生物医学期刊在医学伦理学方面的意识是否有改善,选取2004和2005年出版的12种国外影响因子大于3的SCI收录期刊与11种中国科学引文数据库(CSCD)核心库收录期刊中刊登的论著进行比较.结果显示,国外医学期刊无论在获得伦理委员会批准还是受试者知情同意方面均好于国内医学期刊,而国内一些医学期刊几乎无医学伦理学意识.认为我国医学期刊应从提高编辑人员素质,重视医学伦理学的宣传教育,不同的稿件应区别对待,完善稿件中的知情同意以及其他医学伦理学问题等几个方面入手,积极改善缺乏医学伦理学意识的现状.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号